Effect of Hydroxypropyl Methylcellulose and Microcrystalline Cellulose in Design and Optimization of Nebivolol Hydrochloride Immediate Release Tablets by Response Surface Methodology
Article Sidebar
-
Gastrointestinal Tract, Myocardial Infarction, Microcrystalline Cellulose, Hydroxypropyl Methylcellulose, Immediate Release Tablet
Abstract
The goal of the research is to design and optimize Nebivolol Hydrochloride immediate-release tablet using response surface methodology. Nebivolol Hydrochloride immediate-release tablets used in the treatment of heart attacks, myocardial infarction. Response surface methodology calculations for this optimization study were performed utilizing Minitab 17. Different formulations of immediate-release were prepared by applying 2 factors 3 levels full factorial design using Minitab 17, which gave 9 formulations by using the wet granulation method. Independent variables like the amount of hydroxypropyl methylcellulose (X1), and microcrystalline cellulose (X2) and dependent variables like the per cent drug release at 45 minutes (Y1), disintegration (Y2) were selected for optimization. The prepared batches of Nebivolol Hydrochloride immediate-release tablets were evaluated for the pre-compression and post-compression parameters like weight variation, thickness, hardness, and friability, disintegration, and in-vitro drug release studies. All the Physico-chemical parameters were found satisfactory for prepared tablets. The optimized formulation F7 showed disintegrated in 83 sec, percentage dissolution release 97.85 at the end of 45th minute. The results shows that formulated immediate-release tablets of Nebivolol HCl were better to meet patient compliance with respect to effectiveness.
Full text article
References
Abhilash, A. S., Jayaprakash, S., Nagarajan, M., Dhachinamoorthi, D. 2005. Design and evaluation of timolol maleate ocuserts. Indian J Pharm Sci, 67(3):311–314.
Agarwal, S. P., Vasudha, S., Anitha, P. 1998. Spectrophotometric determination of atenolol and timolol dosage forms via charge-transfer complexation. Indian J Pharm Sci, pages 53–55.
Avachat, A., Kotwal, V. 2007. Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate. AAPS PharmSciTech, 8(4):51–56.
Basak, S. C., Reddy, B. M. J., Mani, K. P. L. 2006. Formulation and release behaviour of sustained release ambroxol hydrochloride HPMC matrix tablet. Indian Journal of Pharmaceutical Sciences, 68(5):594.
Bolton, S., Bon, C. 2004. Drugs and the Pharmaceutical Sciences. In Pharmaceutical Statistics: Practical and Clinical Applications. Marcel Dekker, volume 135.
Bourne, D. W., Pharmacokinetics 2002. Modern Pharmaceutics. Marcel Dekker Inc, pages 67–92.
Bramhanker, D. M. 1995. Controlled release medications. biopharmaceutics and pharmacokinetics a treatise. Vallabh Prakashan, 2:335–75.
Carmen, A. L., Haruviki, H., Jose, G. A., Ramon, M. P., Angel, C. S., C 2002. Soft contact lenses capable of sustained delivery of timolol. J Pharm Sci, 91(10):2182–2192.
Chetoni, P., Bianchi, L. M., Giannaccini, B., Saettone, M. F., Conte, U., Sangalli, M. E. 1996. Ocular Mini-Tablets for Controlled Release of Timolol: Evaluation in Rabbits. Journal of Ocular Pharmacology and Therapeutics, 12(3):245–252.
Chien, Y. W. 1990. Controlled and modulated-release drug delivery systems. In Swarbrick J, Balyan JC. Encyclopedia of Pharmaceutical Technology, pages 281–313.
Colombo, P., Bettini, R., Catellani, P. L., Santi, P., Peppas, N. A. 1999. Drug volume fraction profile in the gel phase and drug release kinetics in hydroxypropylmethyl cellulose matrices containing a soluble drug. European Journal of Pharmaceutical Sciences, 9(1):33–40.
Dayal, P., Pillay, V., Babu, R. J., Singh, M. 2005. Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: Characterization of viscosity, in vitro drug release, droplet size, and dynamic surface tension. AAPS PharmSciTech, 6(4):E573–E585.
Kuksal, A., Tiwary, A. K., Jain, N. K., Jain, S. 2006. Formulation and in vitro, in vivo evaluation of extended-release matrix tablet of Zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers. AAPS PharmSciTech, 7(1):E1–E9.
Palamakula, A., Nutan, M. T. H., Khan, M. A. 2004. Response surface methodology for optimization and characterization of limonene-based coenzyme Q10 self-nanoemulsified capsule dosage form. AAPS PharmSciTech, 5(4):114–121.
Ragonese, R., Macka, M., Hughes, J., Petocz, P. 2002. The use of the Box–Behnken experimental design in the optimisation and robustness testing of a capillary electrophoresis method for the analysis of ethambutol hydrochloride in a pharmaceutical formulation. Journal of Pharmaceutical and Biomedical Analysis, 27(6):995–1007.
Samineni, R., Sumalatha, K., Dharani, G., Rachana, J., Anitha, P., Manasa, K. 2019. Formulation and Evaluation of Oral Disintegrating Tablets of Montelukast Sodium and Desloratidine. Research Journal of Pharmaceutical Dosage Forms and Technology, 11(3):152.
Sharma, N., Pahuja, S., Sharma, N. 2019. Immediate-release tablets: a review. IJPSR, 11:3607–3618.
Singh, B., Chakkal, S. K., Ahuja, N. 2006. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS Pharm Sci Tech, 7:1–9.
Singh, S. K., Dodge, J., Durrani, M. J., Khan, M. A. 1995. Optimization and characterization of controlled release pellets coated with an experimental latex: I. Anionic drug. International Journal of Pharmaceutics, 125(2):243–255.
St. Louis 2007. Bystolic (nebivolol), package insert. MO: Forest Laboratories. Pages 14.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.